[
    {
        "id": "wiki20220301en134_50448",
        "title": "Sirtex",
        "content": "Results from the largest most comprehensive study to date evaluating SIRT in liver metastases from colorectal cancer were presented at ASCO in 2012, ASCO-GI 2013 and ASCO in 2014. The various subsets of the MORE study, led by Andrew S. Kennedy M.D. Physician in Chief, Radiation Oncology Sarah Cannon Research Institute Nashville Tenn., have demonstrated safety and efficacy as well as the same in treating the elderly. The most recent set of data presented at ASCO in 2014 documented the ability to predict success of SIRT using standard laboratory tests prior to treatment. In addition, the global SIRFLOX study which completed patient recruitment in 2013 will evaluate SIR-Spheres microspheres a first-line treatment for colorectal liver metastases.",
        "contents": "Sirtex. Results from the largest most comprehensive study to date evaluating SIRT in liver metastases from colorectal cancer were presented at ASCO in 2012, ASCO-GI 2013 and ASCO in 2014. The various subsets of the MORE study, led by Andrew S. Kennedy M.D. Physician in Chief, Radiation Oncology Sarah Cannon Research Institute Nashville Tenn., have demonstrated safety and efficacy as well as the same in treating the elderly. The most recent set of data presented at ASCO in 2014 documented the ability to predict success of SIRT using standard laboratory tests prior to treatment. In addition, the global SIRFLOX study which completed patient recruitment in 2013 will evaluate SIR-Spheres microspheres a first-line treatment for colorectal liver metastases.",
        "wiki_id": "8295990"
    },
    {
        "id": "wiki20220301en189_697",
        "title": "C-C chemokine receptor type 6",
        "content": "Clinical significance CCR6 has a function in development and metastatic spread of gastrointestinal malignancies. Expression of CCR6 was found to be up-regulated in colorectal cancer. Many patients with colorectal cancer have liver metastases. Colorectal carcinoma cells express CCR6 and CCL20. High level of CCL20 in liver chemoattract colorectal carcinoma cells and cause metastases in liver. Novel research has identified a microRNA that is able to downregulate CCR6 in cancer cell lines. CCR6 has been associated with Crohn's disease. References External links Further reading Chemokine receptors Clusters of differentiation",
        "contents": "C-C chemokine receptor type 6. Clinical significance CCR6 has a function in development and metastatic spread of gastrointestinal malignancies. Expression of CCR6 was found to be up-regulated in colorectal cancer. Many patients with colorectal cancer have liver metastases. Colorectal carcinoma cells express CCR6 and CCL20. High level of CCL20 in liver chemoattract colorectal carcinoma cells and cause metastases in liver. Novel research has identified a microRNA that is able to downregulate CCR6 in cancer cell lines. CCR6 has been associated with Crohn's disease. References External links Further reading Chemokine receptors Clusters of differentiation",
        "wiki_id": "14167673"
    },
    {
        "id": "wiki20220301en010_160871",
        "title": "Colorectal cancer",
        "content": "If there are only a few metastases in the liver or lungs, these may also be removed. Chemotherapy may be used before surgery to shrink the cancer before attempting to remove it. The two most common sites of recurrence of colorectal cancer are the liver and lungs. For peritoneal carcinomatosis cytoreductive surgery, sometimes in combination with HIPEC can be used in an attempt to remove the cancer. Chemotherapy In both cancer of the colon and rectum, chemotherapy may be used in addition to surgery in certain cases. The decision to add chemotherapy in management of colon and rectal cancer depends on the stage of the disease.",
        "contents": "Colorectal cancer. If there are only a few metastases in the liver or lungs, these may also be removed. Chemotherapy may be used before surgery to shrink the cancer before attempting to remove it. The two most common sites of recurrence of colorectal cancer are the liver and lungs. For peritoneal carcinomatosis cytoreductive surgery, sometimes in combination with HIPEC can be used in an attempt to remove the cancer. Chemotherapy In both cancer of the colon and rectum, chemotherapy may be used in addition to surgery in certain cases. The decision to add chemotherapy in management of colon and rectal cancer depends on the stage of the disease.",
        "wiki_id": "206979"
    },
    {
        "id": "wiki20220301en134_50444",
        "title": "Sirtex",
        "content": "Metastatic colorectal cancer Colorectal cancer (CRC), also called colon cancer or large bowel cancer, is the third leading cause of cancer-related death in the western world. An estimated 1.6 million people are diagnosed with the disease worldwide every year. An estimated 50% of CRC patients will show liver metastases. It is this form of metastatic colorectal cancer (mCRC) Sirtex targets with SIR-Spheres microspheres. It has been estimated that in 30-40% of patients with advanced disease, the liver is the only site of spread.",
        "contents": "Sirtex. Metastatic colorectal cancer Colorectal cancer (CRC), also called colon cancer or large bowel cancer, is the third leading cause of cancer-related death in the western world. An estimated 1.6 million people are diagnosed with the disease worldwide every year. An estimated 50% of CRC patients will show liver metastases. It is this form of metastatic colorectal cancer (mCRC) Sirtex targets with SIR-Spheres microspheres. It has been estimated that in 30-40% of patients with advanced disease, the liver is the only site of spread.",
        "wiki_id": "8295990"
    },
    {
        "id": "wiki20220301en195_22240",
        "title": "Hepatic arterial infusion",
        "content": "Hepatic Arterial Infusion (HAI) is a medical procedure that delivers chemotherapy directly to the liver. The procedure, mostly used in combination with systemic chemotherapy, plays a role in the treatment of liver metastases in patients with colorectal cancer (CRC). Although surgical resection remains the standard of care for these liver metastases, majority of patients have lesions that are unresectable. The liver derives its blood supply from two sources – via the hepatic arterial circulation and the portal circulation. Liver metastases get most of their blood supply primarily from the hepatic artery, whereas the normal liver cells get their blood supply from the portal circulation. This allows for chemotherapeutic drugs to be delivered directly to the cancer cells if infused into the hepatic artery.",
        "contents": "Hepatic arterial infusion. Hepatic Arterial Infusion (HAI) is a medical procedure that delivers chemotherapy directly to the liver. The procedure, mostly used in combination with systemic chemotherapy, plays a role in the treatment of liver metastases in patients with colorectal cancer (CRC). Although surgical resection remains the standard of care for these liver metastases, majority of patients have lesions that are unresectable. The liver derives its blood supply from two sources – via the hepatic arterial circulation and the portal circulation. Liver metastases get most of their blood supply primarily from the hepatic artery, whereas the normal liver cells get their blood supply from the portal circulation. This allows for chemotherapeutic drugs to be delivered directly to the cancer cells if infused into the hepatic artery.",
        "wiki_id": "14902164"
    },
    {
        "id": "pubmed23n0088_17937",
        "title": "[Prognosis in synchronous liver metastasis from colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the rectosigmoid colon].",
        "content": "A prospective investigation of 188 patients with cancer of the rectum and rectosigmoid colon with synchronous liver metastases is described. The mean survival time for 183 patients who did not receive any treatment for the liver metastases was six months and only one survived for longer than 37 months. After extirpation of the primary tumour, the most significant prognostic factors were etrahepatic metastases, enlarged liver on account of metastases and more than three liver metastases. Serum basic phosphatases had the greatest significance among a series of laboratory tests. In the sub-groups with the best possible prognoses, the mean survival time was 12 months. 25% five-year survival has been described in the literature following resection of the liver in patients with a maximum of three metastases, no other metastases and age under 70 years. Provided this holds true, liver surgery will be a therapeutic possibility in at least 100 patients per annum in Denmark with synchronous liver metastases and 25 of these will be cured. This figure requires an improved programme for the diagnosis of synchronous liver metastases than at present and the same high frequency of extirpation of the primary colorectal cancer on a national basis which was achieved in the present material.",
        "contents": "[Prognosis in synchronous liver metastasis from colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the rectosigmoid colon]. A prospective investigation of 188 patients with cancer of the rectum and rectosigmoid colon with synchronous liver metastases is described. The mean survival time for 183 patients who did not receive any treatment for the liver metastases was six months and only one survived for longer than 37 months. After extirpation of the primary tumour, the most significant prognostic factors were etrahepatic metastases, enlarged liver on account of metastases and more than three liver metastases. Serum basic phosphatases had the greatest significance among a series of laboratory tests. In the sub-groups with the best possible prognoses, the mean survival time was 12 months. 25% five-year survival has been described in the literature following resection of the liver in patients with a maximum of three metastases, no other metastases and age under 70 years. Provided this holds true, liver surgery will be a therapeutic possibility in at least 100 patients per annum in Denmark with synchronous liver metastases and 25 of these will be cured. This figure requires an improved programme for the diagnosis of synchronous liver metastases than at present and the same high frequency of extirpation of the primary colorectal cancer on a national basis which was achieved in the present material.",
        "PMID": 2660370
    },
    {
        "id": "pubmed23n0021_4901",
        "title": "Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases.",
        "content": "The surgical results were analyzed of 217 patients who had undergone operation for primary colorectal cancer and were found to have synchronous liver metastases. It is recommended that patients with primary operable colorectal cancer who are found to have synchronous liver metastases should at least have an adequate resection of the primary lesion. If the primary lesion is resectable for cure and there are solitary hepatic metastases, then excision of these seems warranted. In most cases this can be accomplished by simple excision or wedge resection, although occasional cases may require lobectomy.",
        "contents": "Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. The surgical results were analyzed of 217 patients who had undergone operation for primary colorectal cancer and were found to have synchronous liver metastases. It is recommended that patients with primary operable colorectal cancer who are found to have synchronous liver metastases should at least have an adequate resection of the primary lesion. If the primary lesion is resectable for cure and there are solitary hepatic metastases, then excision of these seems warranted. In most cases this can be accomplished by simple excision or wedge resection, although occasional cases may require lobectomy.",
        "PMID": 623377
    },
    {
        "id": "wiki20220301en194_24501",
        "title": "ID4",
        "content": "ID4 is not found in normal epitheliums nor adenomas of colorectal cancer. Hypermethylation of ID4 causes silencing of the gene. This has been identified as a significant independent risk factor for poor prognosis of colorectal cancer. It is also frequently observed in liver metastases of colorectal cancer specimens. Developmental disorders Rett syndrome is an X linked neurodevelopment disorder. It is often identified after six to eight months of age in females. In human brain tissue specimens of Rett syndrome patients, the family of ID genes are seen to be significantly increased in expression. Society and culture",
        "contents": "ID4. ID4 is not found in normal epitheliums nor adenomas of colorectal cancer. Hypermethylation of ID4 causes silencing of the gene. This has been identified as a significant independent risk factor for poor prognosis of colorectal cancer. It is also frequently observed in liver metastases of colorectal cancer specimens. Developmental disorders Rett syndrome is an X linked neurodevelopment disorder. It is often identified after six to eight months of age in females. In human brain tissue specimens of Rett syndrome patients, the family of ID genes are seen to be significantly increased in expression. Society and culture",
        "wiki_id": "14813842"
    },
    {
        "id": "pubmed23n0079_10910",
        "title": "Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases.",
        "content": "One hundred and twenty-two patients underwent liver resection for metastases of colorectal cancer within 8 years. Seventy-four of them were treated for metachronous metastases detected in a median of 18 months after resection of the primary tumor. In another 48 patients the metastases were resected at the same time as the primary cancer. Both groups were analysed for disease-free and overall survival, and for peri-operative morbidity. However, neither the type of hepatic resection nor peri-operative morbidity showed relevant differences in the groups, except for the metachronous group, the only group in which operative mortality occurred (6.7%). Survival was not significantly different, being 32 months in the metachronous and 24 months in the synchronous groups (P = 0.051). However, disease-free survival showed significant differences; no patient in the synchronous group experienced a recurrence-free interval of more than 3 years. The median time interval until diagnosis of a recurrence was 10 months after resection of metachronous metastases, but only 6 months in the synchronous group (P = 0.018). The pattern of recurrence showed a much higher proportion of patients with disseminated disease in the synchronous group (95% vs 42%). Therefore, liver resection in synchronous colorectal metastases should be handled very restrictively and adjuvant treatment strategies considered in the future.",
        "contents": "Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases. One hundred and twenty-two patients underwent liver resection for metastases of colorectal cancer within 8 years. Seventy-four of them were treated for metachronous metastases detected in a median of 18 months after resection of the primary tumor. In another 48 patients the metastases were resected at the same time as the primary cancer. Both groups were analysed for disease-free and overall survival, and for peri-operative morbidity. However, neither the type of hepatic resection nor peri-operative morbidity showed relevant differences in the groups, except for the metachronous group, the only group in which operative mortality occurred (6.7%). Survival was not significantly different, being 32 months in the metachronous and 24 months in the synchronous groups (P = 0.051). However, disease-free survival showed significant differences; no patient in the synchronous group experienced a recurrence-free interval of more than 3 years. The median time interval until diagnosis of a recurrence was 10 months after resection of metachronous metastases, but only 6 months in the synchronous group (P = 0.018). The pattern of recurrence showed a much higher proportion of patients with disseminated disease in the synchronous group (95% vs 42%). Therefore, liver resection in synchronous colorectal metastases should be handled very restrictively and adjuvant treatment strategies considered in the future.",
        "PMID": 2379594
    },
    {
        "id": "wiki20220301en010_160890",
        "title": "Colorectal cancer",
        "content": "Epidemiology Globally more than 1 million people get colorectal cancer every year resulting in about 715,000 deaths as of 2010 up from 490,000 in 1990. , it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men (10.0%) with it being the fourth most common cause of cancer death after lung, stomach, and liver cancer. It is more common in developed than developing countries. Globally incidences vary 10-fold with highest rates in Australia, New Zealand, Europe and the US and lowest rates in Africa and South-Central Asia. United States Colorectal cancer is the second highest cause of cancer occurrence and death for men and women in the United States combined. An estimated 141,210 cases were diagnosed in 2011.",
        "contents": "Colorectal cancer. Epidemiology Globally more than 1 million people get colorectal cancer every year resulting in about 715,000 deaths as of 2010 up from 490,000 in 1990. , it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men (10.0%) with it being the fourth most common cause of cancer death after lung, stomach, and liver cancer. It is more common in developed than developing countries. Globally incidences vary 10-fold with highest rates in Australia, New Zealand, Europe and the US and lowest rates in Africa and South-Central Asia. United States Colorectal cancer is the second highest cause of cancer occurrence and death for men and women in the United States combined. An estimated 141,210 cases were diagnosed in 2011.",
        "wiki_id": "206979"
    },
    {
        "id": "pubmed23n0066_14567",
        "title": "Resection of synchronous liver metastases from colorectal cancer.",
        "content": "Whereas resection for metachronous liver metastases from colorectal cancer is considered to be a potentially curative approach, little is known about the prognosis after resection of synchronous liver metastases. In the past, these patients usually underwent only palliative therapy. Therefore, we have analyzed the data of 36 patients who underwent curative hepatic resection of synchronous liver metastases from colorectal carcinomas from 1977 to 1987 at the Department of Surgery, Hannover Medical School. In 19 patients, liver resection was combined with colonic resection; in the other 17 patients, hepatic resection was performed after a median interval of 2 months following resection of the primary tumor. No operative mortality was observed in either of the approaches. The median survival time was 28 months for all patients with a median recurrence-free interval of 13.5 months. Overall 5-year survival probability for all patients was 20%. There were no significant differences observed between immediate or delayed liver resection (median survival 18 months versus 31 months). Survival rates were not different after resection of solitary versus multiple liver metastases (26 versus 28 months). Twenty-one of the 36 patients had a recurrence of their liver metastases. In 7 of them, curative liver resection could be performed again. These 7 patients had a significantly improved survival (p less than 0.05) compared to the residual 14 patients. It is concluded that patients with synchronous liver metastases from colorectal cancer may profit from resection of the primary tumor and liver metastases. Timing of liver resection--immediate versus delayed--obviously has no impact on survival rates.",
        "contents": "Resection of synchronous liver metastases from colorectal cancer. Whereas resection for metachronous liver metastases from colorectal cancer is considered to be a potentially curative approach, little is known about the prognosis after resection of synchronous liver metastases. In the past, these patients usually underwent only palliative therapy. Therefore, we have analyzed the data of 36 patients who underwent curative hepatic resection of synchronous liver metastases from colorectal carcinomas from 1977 to 1987 at the Department of Surgery, Hannover Medical School. In 19 patients, liver resection was combined with colonic resection; in the other 17 patients, hepatic resection was performed after a median interval of 2 months following resection of the primary tumor. No operative mortality was observed in either of the approaches. The median survival time was 28 months for all patients with a median recurrence-free interval of 13.5 months. Overall 5-year survival probability for all patients was 20%. There were no significant differences observed between immediate or delayed liver resection (median survival 18 months versus 31 months). Survival rates were not different after resection of solitary versus multiple liver metastases (26 versus 28 months). Twenty-one of the 36 patients had a recurrence of their liver metastases. In 7 of them, curative liver resection could be performed again. These 7 patients had a significantly improved survival (p less than 0.05) compared to the residual 14 patients. It is concluded that patients with synchronous liver metastases from colorectal cancer may profit from resection of the primary tumor and liver metastases. Timing of liver resection--immediate versus delayed--obviously has no impact on survival rates.",
        "PMID": 1994607
    },
    {
        "id": "wiki20220301en083_301",
        "title": "Hepatectomy",
        "content": "The Pringle manoeuvre is usually performed during a hepatectomy to minimize blood loss - however this can lead to reperfusion injury in the liver due to Ischemia. Complications Bleeding is the most feared technical complication and may be grounds for urgent reoperation. Biliary fistula is also a possible complication, albeit one more amenable to nonsurgical management. Pulmonary complications such as atelectasis and pleural effusion are commonplace, and dangerous in patients with underlying lung disease. Infection is relatively rare. Liver failure is the most serious complication of liver resection; this is a major deterrent in the surgical resection of hepatocellular carcinoma in patients with cirrhosis. It is also a problem, to a lesser degree, in patients with previous hepatectomies (e.g. repeat resections for reincident colorectal cancer metastases).",
        "contents": "Hepatectomy. The Pringle manoeuvre is usually performed during a hepatectomy to minimize blood loss - however this can lead to reperfusion injury in the liver due to Ischemia. Complications Bleeding is the most feared technical complication and may be grounds for urgent reoperation. Biliary fistula is also a possible complication, albeit one more amenable to nonsurgical management. Pulmonary complications such as atelectasis and pleural effusion are commonplace, and dangerous in patients with underlying lung disease. Infection is relatively rare. Liver failure is the most serious complication of liver resection; this is a major deterrent in the surgical resection of hepatocellular carcinoma in patients with cirrhosis. It is also a problem, to a lesser degree, in patients with previous hepatectomies (e.g. repeat resections for reincident colorectal cancer metastases).",
        "wiki_id": "3776505"
    },
    {
        "id": "wiki20220301en083_299",
        "title": "Hepatectomy",
        "content": "Indications Most hepatectomies are performed for the treatment of hepatic neoplasms, both benign or malignant. Benign neoplasms include hepatocellular adenoma, hepatic hemangioma and focal nodular hyperplasia. The most common malignant neoplasms (cancers) of the liver are metastases; those arising from colorectal cancer are among the most common, and the most amenable to surgical resection. The most common primary malignant tumour of the liver is the hepatocellular carcinoma. Hepatectomy may also be the procedure of choice to treat intrahepatic gallstones or parasitic cysts of the liver. Partial hepatectomies are also performed to remove a portion of a liver from a live donor for transplantation. Technique",
        "contents": "Hepatectomy. Indications Most hepatectomies are performed for the treatment of hepatic neoplasms, both benign or malignant. Benign neoplasms include hepatocellular adenoma, hepatic hemangioma and focal nodular hyperplasia. The most common malignant neoplasms (cancers) of the liver are metastases; those arising from colorectal cancer are among the most common, and the most amenable to surgical resection. The most common primary malignant tumour of the liver is the hepatocellular carcinoma. Hepatectomy may also be the procedure of choice to treat intrahepatic gallstones or parasitic cysts of the liver. Partial hepatectomies are also performed to remove a portion of a liver from a live donor for transplantation. Technique",
        "wiki_id": "3776505"
    },
    {
        "id": "pubmed23n0049_21529",
        "title": "[Synchronous resection of liver metastases of colorectal cancers].",
        "content": "From 1981 to 1991, 161 patients underwent liver resection for colorectal secondaries with curative intent. In 57 patients metastases were synchronous to the primary tumor and were resected in 29 cases simultaneously and in 28 patients after a 2-week delay. Median survival of 28 months is similar to the treatment result for metachronous metastases. However, the recurrence-free interval was significantly shorter (7.5 months vs 11.8 months; p = 0.05). Radical resection of the primary tumor contributes to the treatment result; segmental resections of colorectum without lymphadenectomy should be avoided. Indication for liver resection should be made in the case of solitary lesions and in patients without extrahepatic disease. The type of resection for the primary tumor or for liver metastases does not influence survival, morbidity, or operative mortality.",
        "contents": "[Synchronous resection of liver metastases of colorectal cancers]. From 1981 to 1991, 161 patients underwent liver resection for colorectal secondaries with curative intent. In 57 patients metastases were synchronous to the primary tumor and were resected in 29 cases simultaneously and in 28 patients after a 2-week delay. Median survival of 28 months is similar to the treatment result for metachronous metastases. However, the recurrence-free interval was significantly shorter (7.5 months vs 11.8 months; p = 0.05). Radical resection of the primary tumor contributes to the treatment result; segmental resections of colorectum without lymphadenectomy should be avoided. Indication for liver resection should be made in the case of solitary lesions and in patients without extrahepatic disease. The type of resection for the primary tumor or for liver metastases does not influence survival, morbidity, or operative mortality.",
        "PMID": 1493326
    },
    {
        "id": "pubmed23n0083_16493",
        "title": "[Intra-arterial infusion chemotherapy of liver metastases in colorectal cancer].",
        "content": "We report the complications and the results of intra-arterial infusion chemotherapy (IAIC) for liver metastases in colorectal cancer. Fifteen synchronous liver metastases and 11 metachronous liver metastases were treated from September 1986 to February 1989. Eight cases had H1 (metastases in one lobe only), 11 cases H2 (a few scattered metastases in both lobes) and 7 cases had H3 (numerous metastases in both lobes). Eight cases underwent hepatic resection and 20 cases were treated by IAIC with implantable reservoir. Incidence of complication was decreased from 75% to 17% by the improved technique of hepatic arterial catheter intubation. Median survival was 12 months, 20 months and 8 months, respectively. When used with MMC, the IAIC showed unsatisfactory results. We should therefore investigate possible use of alternative drugs, their optimum dosages, and the regimens for improved chemotherapy.",
        "contents": "[Intra-arterial infusion chemotherapy of liver metastases in colorectal cancer]. We report the complications and the results of intra-arterial infusion chemotherapy (IAIC) for liver metastases in colorectal cancer. Fifteen synchronous liver metastases and 11 metachronous liver metastases were treated from September 1986 to February 1989. Eight cases had H1 (metastases in one lobe only), 11 cases H2 (a few scattered metastases in both lobes) and 7 cases had H3 (numerous metastases in both lobes). Eight cases underwent hepatic resection and 20 cases were treated by IAIC with implantable reservoir. Incidence of complication was decreased from 75% to 17% by the improved technique of hepatic arterial catheter intubation. Median survival was 12 months, 20 months and 8 months, respectively. When used with MMC, the IAIC showed unsatisfactory results. We should therefore investigate possible use of alternative drugs, their optimum dosages, and the regimens for improved chemotherapy.",
        "PMID": 2506826
    }
]